SERUM LIPOPOLYSACCHARIDE-BINDING PROTEIN (LBP), AND SOLUBLE CD14 RECEPTOR (SCD14) ARE MARKERS OF DISEASE ACTIVITY IN PATIENTS WITH CROHN'S DISEASE

(1) st Department of Medicine, Semmelweis University, Budapest

(2) 2nd Department of Medicine

(3) 1st Department of Medicine, University of Szeged, Szeged

(4) Institute of Surgery, University of Debrecen, Debrecen, Hungary



This item was part of the IMMFLAMMATORY BOWEL DISEASE I session at Gastro 2009 UEGW/WCOG London (17th UEGW)